Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FDU85
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,997
Award facts
- Contract value 100% obligated
- $21,997.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a contract value of $21,997.03. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively evaluated. The order is scheduled for ultimate completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for federal military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability in supplying a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This particular delivery order for Gemtesa, a medication used in urology treatment, exemplifies the routine pharmaceutical fulfillment that AmerisourceBergen executes through its prime indefinite delivery contract with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB26FDU85?
SPE2DB26FDU85 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FDU85 worth?
The government has obligated $21,997 on SPE2DB26FDU85.
Is contract SPE2DB26FDU85 an order under another contract?
Yes. SPE2DB26FDU85 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDU85 competed?
The extent of competition for SPE2DB26FDU85 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award